GE HealthCare Technologies GEHC Ratios (2022-2026)

NASDAQ GEHC
$65.93 -0.85 (-1.27%)
As of: Sep 9, 2026 · 12:14 PM EDT
Reported Financials

GE HealthCare Technologies Quarterly Ratios

Periods 18 quarters
Latest Jun 2026

GE HealthCare Technologies reported a gross margin of 41.17% and a net margin of 10.84% for the quarter ended Jun 2026. These financial ratios cover 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 38.64%40.05%38.75%39.13%40.17%40.27%40.13%41.41%40.90%41.37%41.66%42.77%42.12%39.64%38.69%39.68%38.53%41.17%
EBT Margin 12.27%14.25%13.59%14.54%11.60%11.83%13.19%11.70%11.01%11.94%13.53%15.68%14.49%12.24%12.50%14.41%9.84%13.09%
EBIT Margin 11.72%14.07%13.22%15.74%11.88%11.83%12.80%13.23%11.61%12.56%13.90%15.06%13.17%13.06%12.70%14.51%10.04%13.96%
EBITDA Margin 11.72%14.07%13.22%15.74%11.88%11.83%12.80%13.23%11.61%12.56%13.90%15.06%13.17%13.06%12.70%14.51%10.04%13.96%
Operating Margin 11.72%14.07%13.22%15.74%11.88%11.83%12.80%13.23%11.61%12.56%13.90%15.06%13.17%13.06%12.70%14.51%10.04%13.96%
Net Margin 8.96%10.82%10.64%11.22%4.02%8.68%7.78%7.74%8.04%8.84%9.66%13.56%12.31%9.99%9.02%10.57%8.01%10.84%
FCF Margin 8.47%-1.74%11.98%19.97%6.90%-2.84%11.82%18.36%5.89%-3.78%13.41%15.25%2.05%0.16%9.39%16.08%2.18%1.28%
Efficiency
Inventory AverageInventory Avg. 2.21B2.26B2.20B2.04B1.97B2.01B2.07B2.03B2.05B2.22B2.29B2.27B2.29B2.42B
Assets AverageAssets Avg. 30.09B32.47B32.35B32.42B32.33B32.03B32.85B33.47B33.34B34.54B35.81B36.52B37.02B37.19B
Invested CapitalInvested Cap. 17.64B17.12B17.36B17.41B18.60B18.69B19.07B20.66B20.42B21.97B24.02B24.31B21.41B20.83B21.09B
Asset Utilization RatioAsset Util. 0.620.590.600.600.600.610.600.590.590.580.570.560.570.57
Leverage & Solvency
Interest Coverage RatioInterest Cover 127.2552.58302.5013.174.114.164.475.264.434.645.206.625.725.795.887.885.366.48
Debt Ratio 0.300.320.320.320.350.350.350.360.360.380.400.400.300.270.27
Times Interest Earned 127.2552.58302.5013.174.114.164.475.264.434.645.206.625.725.795.887.885.366.48
Dividends & Payouts
Dividend Coverage RatioDiv. Cover 15.4826.7928.7926.7130.5733.5742.4136.7531.2514.5037.6325.6935.88
FCF Payout RatioFCF Cover -0.200.020.010.05-0.080.020.020.162.000.070.020.140.24
Dividend YieldDiv. Yield 0.07%0.05%0.04%0.03%0.04%0.03%0.05%0.04%0.05%0.09%0.04%0.05%0.06%
Payout Ratio 0.060.040.030.040.030.030.020.030.030.070.030.040.03
Valuation
Price to EarningsP/E 47.83197.3188.3982.6087.36110.9283.1491.2349.5962.8567.6473.7362.0978.7850.37
Price to SalesP/S 5.377.927.676.426.768.927.358.826.727.746.756.656.566.315.46
Price to BookP/B 2.835.575.194.344.935.594.555.144.224.013.473.423.603.032.63
Enterprise Value 25.28B35.16B35.21B28.71B32.87B39.10B33.74B39.48B33.05B34.69B30.27B30.38B33.07B30.31B27.03B
EV to EBIT 32.5362.9061.7846.5447.7072.4055.5058.4141.2655.1546.2946.5339.9958.8536.58
EV to EBITDA 32.5362.9061.7846.5447.7072.4055.5058.4141.2655.1546.2946.5339.9958.8536.58
Market Capitalization 26.50B37.29B36.95B30.97B35.21B41.48B35.58B42.88B35.75B36.96B33.82B34.21B37.38B32.38B28.91B
Price to FCFP/FCF 26.88114.75-269.7054.3436.83151.40-194.4465.7644.08377.100.00B70.8340.81289.10425.18
EV to FCF 25.64108.18-257.0350.3834.38142.69-184.3860.5640.75353.990.00B62.9136.11270.62397.55
EV to CFO 23.7875.13-525.5644.1831.3093.31-283.5453.2136.20138.76322.0451.2431.50104.51160.91
Return Ratios
Return on Sales [ROS]ROS 11.72%14.07%13.22%15.74%11.88%11.83%12.80%13.23%11.61%12.56%13.90%15.06%13.17%13.06%12.70%14.51%10.04%13.96%
Return on Capital Employed [ROCE]ROCE 11.77%10.09%10.18%10.39%10.29%10.35%10.39%10.97%11.61%11.13%10.63%10.08%9.30%9.47%
Return on Invested Capital [ROIC]ROIC 11.30%11.13%10.39%9.27%9.04%9.04%9.28%10.15%10.44%9.94%9.32%9.40%9.60%10.05%
Return on Assets [ROA]ROA 6.47%5.80%5.48%4.98%5.01%5.06%5.26%6.13%6.75%6.70%6.39%5.90%5.34%5.52%